Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Does volume matter? Impact of collection volumes on detection of biomarkers and HPV DNA in first-void urine
It is well-established that Human Papillomavirus (HPV), the primary cause of cervical cancer can be detected in first-void urine. The study by Laura Téblick (University of Antwerp, Belgium) investigated whether different first-void urine volumes collected with Colli-Pee affects the detection of...